• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Allele-dropout using PCR-based diagnosis for the splicing mutation in intron-2 of the CYP21B-gene: successful amplification with a Taq/Pwo-polymerase mixture.

作者信息

Schulze E, Bettendorf M, Maser-Gluth C, Decker M, Schwabe U

机构信息

Department of Pharmacology, University of Heidelberg, Germany.

出版信息

Endocr Res. 1998 Aug-Nov;24(3-4):637-41. doi: 10.3109/07435809809032662.

DOI:10.3109/07435809809032662
PMID:9888552
Abstract

The splicing mutation in intron 2 (nucleotide 656) of the 21-hydroxylase gene (CYP21B) is the most common mutation causing congenital adrenal hyperplasia (CAH). Homozygosity for nt656G is associated with the classical phenotype of CAH. In several studies, a number of clinically asymptomatic relatives of CAH-patients were genotyped as nt656G homozygotes. We have proposed that the putative asymptomatic nt656G/G individuals are incorrectly typed due to dropout of one allele (in most cases nt656C) during PCR amplification. Here, we report the successful amplification of all alleles at nt656 with a Taq/Pwo DNA polymerase mixture in the primary PCR reaction. The results were independent from the type of polymerase used for sequencing reactions as the second step in mutation analysis.

摘要

相似文献

1
Allele-dropout using PCR-based diagnosis for the splicing mutation in intron-2 of the CYP21B-gene: successful amplification with a Taq/Pwo-polymerase mixture.
Endocr Res. 1998 Aug-Nov;24(3-4):637-41. doi: 10.3109/07435809809032662.
2
Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees.在先天性肾上腺皮质增生症(CAH)受累家系中,使用基于PCR的方法诊断21-羟化酶缺乏症时非扩增性CYP21基因的鉴定。
Hum Mol Genet. 1996 Dec;5(12):2039-48. doi: 10.1093/hmg/5.12.2039.
3
Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification.采用聚合酶链反应扩增技术对21-羟化酶缺乏症中的CYP21B基因进行直接分析。
Mol Endocrinol. 1990 Jan;4(1):125-31. doi: 10.1210/mend-4-1-125.
4
Molecular identification of combined homozygous and compound heterozygous mutations in the CYP21 gene in simple virilizing congenital adrenal hyperplasia in Taiwan.台湾单纯性男性化型先天性肾上腺皮质增生症中CYP21基因纯合和复合杂合突变的分子鉴定
Acta Paediatr Taiwan. 2003 Nov-Dec;44(6):339-42.
5
[Analysis of the spectra of mutational damage of the 21-hydroxylase gene in patients with adreno-genital syndrome].[肾上腺生殖器综合征患者21-羟化酶基因突变损伤谱分析]
Genetika. 2000 Aug;36(8):1147-9.
6
Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia.荧光聚合酶链反应和自动片段分析在先天性肾上腺皮质增生症21-羟化酶缺乏症植入前基因诊断中的应用
Mol Hum Reprod. 1999 Jul;5(7):691-6. doi: 10.1093/molehr/5.7.691.
7
de novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings.新发突变在一个HLA相同的受累和未受累兄弟姐妹家庭中导致类固醇21-羟化酶缺乏症。
J Clin Endocrinol Metab. 1993 Jul;77(1):86-9. doi: 10.1210/jcem.77.1.8325964.
8
Identification of molecular defects causing congenital adrenal hyperplasia by cloning and differential hybridization of polymerase chain reaction-amplified 21-hydroxylase (CYP21) genes.
DNA Cell Biol. 1992 Jun;11(5):359-68. doi: 10.1089/dna.1992.11.359.
9
Salt-wasting congenital adrenal hyperplasia: detection of mutations in CYP21B gene in a Chilean population.失盐型先天性肾上腺皮质增生症:智利人群中CYP21B基因突变的检测
J Clin Endocrinol Metab. 1998 Sep;83(9):3357-60. doi: 10.1210/jcem.83.9.5071.
10
Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.应用聚合酶链反应和单链构象多态性对先天性类固醇21-羟化酶缺乏症患者及携带者基因进行分子分析。
J Clin Invest. 1993 Nov;92(5):2182-90. doi: 10.1172/JCI116820.

引用本文的文献

1
Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.类固醇21-羟化酶缺乏症的分子诊断:一种实用方法
Front Endocrinol (Lausanne). 2022 Mar 29;13:834549. doi: 10.3389/fendo.2022.834549. eCollection 2022.
2
Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.21-羟化酶缺陷导致先天性肾上腺皮质增生症的 In2G 变异特征。
Front Endocrinol (Lausanne). 2022 Jan 24;12:788812. doi: 10.3389/fendo.2021.788812. eCollection 2021.
3
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.
EMQN 21-羟化酶缺陷症分子遗传学检测与报告的最佳实践指南
Eur J Hum Genet. 2020 Oct;28(10):1341-1367. doi: 10.1038/s41431-020-0653-5. Epub 2020 Jul 2.
4
Targeted sequencing identifies novel variants in common and rare MODY genes.靶向测序鉴定常见和罕见 MODY 基因中的新型变异。
Mol Genet Genomic Med. 2019 Dec;7(12):e962. doi: 10.1002/mgg3.962. Epub 2019 Oct 8.
5
Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.液相色谱-串联质谱法测定类固醇用于监测21-羟化酶缺乏症。
Endocr Connect. 2018 Dec;7(12):1542-1550. doi: 10.1530/EC-18-0453.
6
Machine learning approaches for phenotype-genotype mapping: predicting heterozygous mutations in the CYP21B gene from steroid profiles.用于表型-基因型映射的机器学习方法:从类固醇谱预测CYP21B基因中的杂合突变。
Eur J Endocrinol. 2005 Aug;153(2):301-5. doi: 10.1530/eje.1.01957.
7
The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency.嵌合型CYP21P/CYP21基因与21-羟化酶缺乏症
J Hum Genet. 2004;49(2):65-72. doi: 10.1007/s10038-003-0115-2. Epub 2004 Jan 17.
8
Molecular diagnostics in preimplantation genetic diagnosis.植入前基因诊断中的分子诊断学
J Mol Diagn. 2002 Feb;4(1):11-29. doi: 10.1016/S1525-1578(10)60676-9.
9
An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.类固醇21-羟化酶缺乏症的分子诊断概述。
J Mol Diagn. 2001 May;3(2):49-54. doi: 10.1016/S1525-1578(10)60651-4.